BIOMAT Database Logo BIOMAT Database Logo

[Treatment of HCV-associated cryoglobulinemic glomerulonephritis]. 2009

S Laurino, and S Borrelli, and F Catapano, and S Mascia, and P D'Angio', and M Calabria, and M Grimaldi, and A Salvio, and R Minutolo, and L De Nicola, and G Conte
Cattedra di Nefrologia, Seconda Universita' degli Studi, Napoli, Italy.

HCV-related membranoproliferative glomerulonephritis is the most common cause of hepatitis C-associated renal disease. Its treatment is still under debate and based on scant experimental evidence. The recommended therapeutic strategy depends on the severity of the kidney disease. The first-line treatment for patients with mild to moderate clinical and histological kidney damage is antiviral therapy with pegylated interferon alpha and ribavirin for 48 weeks combined with symptomatic treatment (diuretics, angiotensin converting enzyme inhibitors and angiotensin receptor blockers). In case of severe renal involvement (nephrotic syndrome, nephritic syndrome and/or progressive renal failure, high activity score of glomerulonephritis on light microscopy), the initial treatment may consist of sequential administration of immunosuppressive therapies (plasmapheresis, corticosteroids and cyclophosphamide) and antiviral agents, although no definitive data are yet available from the literature. B-cell depleting agents such as rituximab may be an alternative to conventional therapy in refractory or intolerant patients. Large randomized and controlled clinical trials are needed to establish guidelines for the treatment of HCV-related cryoglobulinemic glomerulonephritis.

UI MeSH Term Description Entries
D007155 Immunologic Factors Biologically active substances whose activities affect or play a role in the functioning of the immune system. Biological Response Modifier,Biomodulator,Immune Factor,Immunological Factor,Immunomodulator,Immunomodulators,Biological Response Modifiers,Biomodulators,Factors, Immunologic,Immune Factors,Immunological Factors,Modifiers, Biological Response,Response Modifiers, Biological,Factor, Immune,Factor, Immunological,Factors, Immune,Factors, Immunological,Modifier, Biological Response,Response Modifier, Biological
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D003449 Cryoglobulinemia A condition characterized by the presence of abnormal quantities of CRYOGLOBULINS in the blood. Upon cold exposure, these abnormal proteins precipitate into the microvasculature leading to restricted blood flow in the exposed areas. Cryoglobulinemias
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069283 Rituximab A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS. CD20 Antibody, Rituximab,GP2013,IDEC-C2B8,IDEC-C2B8 Antibody,Mabthera,Rituxan,IDEC C2B8,IDEC C2B8 Antibody,Rituximab CD20 Antibody
D000465 Algorithms A procedure consisting of a sequence of algebraic formulas and/or logical steps to calculate or determine a given task. Algorithm
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral

Related Publications

S Laurino, and S Borrelli, and F Catapano, and S Mascia, and P D'Angio', and M Calabria, and M Grimaldi, and A Salvio, and R Minutolo, and L De Nicola, and G Conte
[Monoclonal antibodies to B-lymphocytes (rituximab) in the treatment of HCV-associated severe cryoglobulinemic glomerulonephritis].
January 2007, Terapevticheskii arkhiv,
S Laurino, and S Borrelli, and F Catapano, and S Mascia, and P D'Angio', and M Calabria, and M Grimaldi, and A Salvio, and R Minutolo, and L De Nicola, and G Conte
[HCV-associated cryoglobulinemic vasculitis].
January 2012, Terapevticheskii arkhiv,
S Laurino, and S Borrelli, and F Catapano, and S Mascia, and P D'Angio', and M Calabria, and M Grimaldi, and A Salvio, and R Minutolo, and L De Nicola, and G Conte
[SEVERE HCV-ASSOCIATED CRYOGLOBULINEMIC VASCULITIS].
January 2015, Klinicheskaia meditsina,
S Laurino, and S Borrelli, and F Catapano, and S Mascia, and P D'Angio', and M Calabria, and M Grimaldi, and A Salvio, and R Minutolo, and L De Nicola, and G Conte
Fludarabine treatment of cryoglobulinemic glomerulonephritis.
September 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation,
S Laurino, and S Borrelli, and F Catapano, and S Mascia, and P D'Angio', and M Calabria, and M Grimaldi, and A Salvio, and R Minutolo, and L De Nicola, and G Conte
[Steroids, interferon-alpha and ribavirin treatment of cryoglobulinemic glomerulonephritis concurrent with HCV infection].
January 2002, Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia,
S Laurino, and S Borrelli, and F Catapano, and S Mascia, and P D'Angio', and M Calabria, and M Grimaldi, and A Salvio, and R Minutolo, and L De Nicola, and G Conte
Antiviral therapy for HCV-associated cryoglobulinemic glomerulonephritis: case report and review of the literature.
January 2012, Kidney & blood pressure research,
S Laurino, and S Borrelli, and F Catapano, and S Mascia, and P D'Angio', and M Calabria, and M Grimaldi, and A Salvio, and R Minutolo, and L De Nicola, and G Conte
HCV-related cryoglobulinemic glomerulonephritis: implications of antiviral and immunosuppressive therapies.
January 2007, Acta bio-medica : Atenei Parmensis,
S Laurino, and S Borrelli, and F Catapano, and S Mascia, and P D'Angio', and M Calabria, and M Grimaldi, and A Salvio, and R Minutolo, and L De Nicola, and G Conte
Clinical outcome of HCV-associated cryoglobulinemic glomerulonephritis following treatment with direct acting antiviral agents: a case-based review.
December 2019, Clinical rheumatology,
S Laurino, and S Borrelli, and F Catapano, and S Mascia, and P D'Angio', and M Calabria, and M Grimaldi, and A Salvio, and R Minutolo, and L De Nicola, and G Conte
Successful treatment of HCV-related cryoglobulinemic glomerulonephritis with double-filtration plasmapheresis and interferon combination therapy.
August 2010, Clinical and experimental nephrology,
S Laurino, and S Borrelli, and F Catapano, and S Mascia, and P D'Angio', and M Calabria, and M Grimaldi, and A Salvio, and R Minutolo, and L De Nicola, and G Conte
[Cryoglobulinemic nephritis associated with chronic HCV infection].
January 2000, Terapevticheskii arkhiv,
Copied contents to your clipboard!